Walgreens Boots Alliance (WBA) Stock
Consumer staples company. Here's the price, business snapshot, and what's worth knowing about Walgreens Boots Alliance in June 2026.
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
Stock Performance Snapshot
Analyst Rating
Analysts suggest maintaining Walgreens Boots stock, with a target price of $13.71 indicating potential growth.
Financial Health
Walgreens Boots Alliance is generating stable revenue and cash flow, but profit margins are relatively low.
Dividend
Walgreens Boots Alliance's high dividend yield of 8.73% is appealing for those seeking dividend income. If you invested $1000 you would be paid $87.30 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
Kroger
Operates grocery stores, multi-department stores, marketplace and jewelry stores
SYSCO CORP
Distributor of food service products
CASEY'S GENERAL STORES INC
Casey's General Stores, Inc. operates convenience stores.
Baskets Featuring WBA
Walmart Succession Plan Explained | Market Effects
Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.
Published: November 17, 2025
Explore BasketObesity Drug Pricing | Pharma Investment Theme
New agreements with Eli Lilly and Novo Nordisk are set to dramatically lower the cost of popular weight-loss drugs, making them accessible to millions through Medicare. This creates an investment opportunity centered on the major pharmaceutical companies involved and the broader supply chain that will support the expected surge in demand.
Published: November 8, 2025
Explore BasketWalgreens Restructuring Explained: Investment Shifts
Following its acquisition by Sycamore Partners, Walgreens has gone private and split into five companies. This theme explores the investment opportunities created by the newly independent healthcare and retail entities.
Published: September 2, 2025
Explore BasketWalgreens' Restructuring: A New Healthcare Landscape
Following its $10 billion acquisition by Sycamore Partners, Walgreens is going private and splitting into five separate companies. This major restructuring of a key industry player could create significant opportunities for competitors and specialized healthcare service providers to capture market share.
Published: August 29, 2025
Explore BasketDigital Warehouse: Costco's Growth
This carefully selected group of stocks captures the powerful hybrid retail model driving Costco's impressive 8% sales surge. Handpicked by our analysts, these companies represent every part of this thriving ecosystem, from e-commerce platforms and global logistics to the consumer brands making this retail revolution possible.
Published: July 11, 2025
Explore BasketHigh-Income Paycheck
Own a slice of established companies that pay you regularly through high dividends. These carefully selected stocks are chosen by financial experts to provide a steady stream of passive income, helping you earn money while you sleep.
Published: June 18, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.